Big Pharma spinout on Peninsula targets childhood liver diseases, $86M IPO

//Big Pharma spinout on Peninsula targets childhood liver diseases, $86M IPO

Big Pharma spinout on Peninsula targets childhood liver diseases, $86M IPO

Mike Grey four years ago sold his Lumena Pharmaceuticals Inc. — including two drugs targeting liver diseases — to Shire plc. On Friday, his new Peninsula company filed for an $86.25 million initial public offering to take those same two drugs deeper into the clinical trials. Mirum Pharmaceuticals Inc., a 24-employee company in Foster City, said in a Securities and Exchange Commission filing that it expects to use the money to complete a late-stage clinical trial of the drug marlixibat and start…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-06-21T21:41:05+00:00 June 21st, 2019|Healthcare|

About the Author: